Niagen Bioscience Inc

NASDAQ: NAGE · Real-Time Price · USD
9.61
-0.51 (-5.04%)
At close: Aug 19, 2025, 3:59 PM
9.63
0.26%
After-hours: Aug 19, 2025, 07:32 PM EDT

Niagen Bioscience Inc Revenue

Niagen Bioscience Inc reported an annual revenue of $99.6M, reflecting a 19.18% growth. For the quarter ending June 30, 2025, Niagen Bioscience Inc generated $31.12M in revenue.
Revenue (ttm)
99.6M
Revenue Growth
19.18%
Price / Sales Ratio
4.55
Revenue / Employee
957.66K
Employees
104
Market Cap
766.03M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 99.6M +19.18%
Dec 31, 2023 83.57M +15.99%
Dec 31, 2022 72.05M +6.82%
Dec 31, 2021 67.45M +13.82%
Dec 31, 2020 59.26M +28.01%
Dec 31, 2019 46.29M +46.69%
Dec 31, 2018 31.56M +48.85%
Dec 31, 2017 21.2M -2.14%
Dec 31, 2016 21.66M +21.13%
Dec 31, 2015 17.88M +16.79%
Dec 31, 2014 15.31M +50.71%
Dec 31, 2013 10.16M -12.48%
Dec 31, 2012 11.61M +43.12%
Dec 31, 2011 8.11M +7.22%
Dec 31, 2010 7.57M +30.95%
Dec 31, 2009 5.78M +28.22%
Dec 31, 2008 4.51M +Infinity%
Nov 30, 2007 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.